The complement inhibitors crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells

Journal of Immunology

Volumn 185, Issue 5, 2010, Pages 3086-3094

  Renner, Brandon ^a   Coleman, Kathrin ^a   Goldberg, Ryan ^a   Amura, Claudia ^a   Holland Neidermyer, Amanda ^a   Pierce, Kathryn ^a   Orth, Heather N ^a   Molina, Hector ^b   Ferreira, Viviana P ^c   Cortes, Claudio ^c   Pangburn, Michael K ^d   Holers, V Michael ^a   Thurman, Joshua M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT FACTOR H; COMPLEMENT INHIBITOR CRRY; REGULATOR PROTEIN; UNCLASSIFIED DRUG; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR; CRRY PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASOLATERAL MEMBRANE; CELL INTERACTION; CELL PROTECTION; CELL SURFACE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; EPITHELIUM CELL; FEMALE; KIDNEY INJURY; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURFACE PROPERTY; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; KIDNEY TUBULE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN BINDING;

ANIMALS; CELLS, CULTURED; COMPLEMENT FACTOR H; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT PATHWAY, ALTERNATIVE; EPITHELIAL CELLS; FEMALE; KIDNEY TUBULES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, COMPLEMENT;

EID: 78049388842     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000111     Document Type: Article

References (41)

1. Sheerin, N. S., T. Springall, M. C. Carroll, B. Hartley, and S. H. Sacks. 1997. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin. Exp. Immunol. 110: 403-409.
2. Couser, W. G. 1998. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol. Dial. Transplant. 13(Suppl. 1): 10-15.
3. Quigg, R. J., A. Lim, M. Haas, J. J. Alexander, C. He, and M. C. Carroll. 1998. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 53: 320-330.
4. Zhou, W., C. A. Farrar, K. Abe, J. R. Pratt, J. E. Marsh, Y. Wang, G. L. Stahl, and S. H. Sacks. 2000. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 105: 1363-1371.
5. Thurman, J. M., D. Ljubanovic, C. L. Edelstein, G. S. Gilkeson, and V. M. Holers. 2003. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J. Immunol. 170: 1517-1523.
6. Pratt, J. R., S. A. Basheer, and S. H. Sacks. 2002. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8: 582-587.
7. Rangan, G. K., J. W. Pippin, J. D. Coombes, and W. G. Couser. 2005. C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria. Kidney Int. 67: 492-503.
8. Rangan, G. K., J. W. Pippin, and W. G. Couser. 2004. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int. 66: 1838-1848.
9. Dragon-Durey, M. A., and V. Frémeaux-Bacchi. 2005. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin. Immunopathol. 27: 359-374.
10. Pickering, M. C., and H. T. Cook. 2008. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin. Exp. Immunol. 151: 210-230.
11. Pickering, M. C., H. T. Cook, J. Warren, A. E. Bygrave, J. Moss, M. J. Walport, and M. Botto. 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet.: 424-428.
12. Smith, R. J., J. Alexander, P. N. Barlow, M. Botto, T. L. Cassavant, H. T. Cook, S. R. de Córdoba, G. S. Hageman, T. S. Jokiranta, W. J. Kimberling, et al; Dense Deposit Disease Focus Group. 2007. New approaches to the treatment of dense deposit disease. J. Am. Soc. Nephrol. 18: 2447-2456.
13. Zipfel, P. F., S. Heinen, M. Józsi, and C. Skerka. 2006. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol. Immunol. 43: 97-106.
14. Pickering, M. C., E. G. de Jorge, R. Martinez-Barricarte, S. Recalde, A. Garcia-Layana, K. L. Rose, J. Moss, M. J. Walport, H. T. Cook, S. R. de Córdoba, and M. Botto. 2007. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J. Exp. Med. 204: 1249-1256.
15. Watanabe, H., G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164: 786-794.
16. Kim, D. D., and W. C. Song. 2006. Membrane complement regulatory proteins. Clin. Immunol. 118: 127-136.
17. Alexander, J. J., and R. J. Quigg. 2007. The simple design of complement factor H: Looks can be deceiving. Mol. Immunol. 44: 123-132.
18. Ferreira, V. P., and M. K. Pangburn. 2007. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. Blood 110: 2190-2192.
19. Ichida, S., Y. Yuzawa, H. Okada, K. Yoshioka, and S. Matsuo. 1994. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int. 46: 89-96.
20. Barilla-LaBarca, M. L., M. K. Liszewski, J. D. Lambris, D. Hourcade, and J. P. Atkinson. 2002. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J. Immunol. 168: 6298-6304.
21. Thurman, J. M., D. Ljubanović, P. A. Royer, D. M. Kraus, H. Molina, N. P. Barry, G. Proctor, M. Levi, and V. M. Holers. 2006. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J. Clin. Invest. 116: 357-368.
22. Bao, L., Y. Wang, A. Chang, A. W. Minto, J. Zhou, H. Kang, M. Haas, and R. J. Quigg. 2007. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. J. Am. Soc. Nephrol. 18: 811-822.
23. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316.
24. Xu, C., D. Mao, V. M. Holers, B. Palanca, A. M. Cheng, and H. Molina. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287: 498-501.
25. Matsumoto, M., W. Fukuda, A. Circolo, J. Goellner, J. Strauss-Schoenberger, X. Wang, S. Fujita, T. Hidvegi, D. D. Chaplin, and H. R. Colten. 1997. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. USA 94: 8720-8725.
26. Thurman, J. M., D. M. Kraus, G. Girardi, D. Hourcade, H. J. Kang, P. A. Royer, L. M. Mitchell, P. C. Giclas, J. Salmon, G. Gilkeson, and V. M. Holers. 2005. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol. Immunol. 42: 87-97.
27. Biancone, L., S. David, V. Della Pietra, G. Montrucchio, V. Cambi, and G. Camussi. 1994. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int. 45: 451-460.
28. Gaarkeuken, H., M. A. Siezenga, K. Zuidwijk, C. van Kooten, T. J. Rabelink, M. R. Daha, and S. P. Berger. 2008. Complement activation by tubular cells is mediated by properdin binding. Am. J. Physiol. Renal Physiol. 295: F1397-F1403.
29. Endo, M., Y. Fuke, M. Tamano, M. Hidaka, I. Ohsawa, T. Fujita, and H. Ohi. 2004. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy. Nephron Clin. Pract. 97: c147-c153.
30. Tamano, M., Y. Fuke, M. Endo, I. Ohsawa, T. Fujita, and H. Ohi. 2002. Urinary complement factor H in renal disease. Nephron 92: 705-707.
31. Cosio, F. G., D. D. Sedmak, J. D. Mahan, and N. S. Nahman, Jr. 1989. Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int. 36: 100-107.
32. Tamai, H., S. Matsuo, A. Fukatsu, K. Nishikawa, N. Sakamoto, K. Yoshioka, N. Okada, and H. Okada. 1991. Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study. Clin. Exp. Immunol. 84: 256-262.
33. Mao, D., X. Wu, C. Deppong, L. D. Friend, G. Dolecki, D. M. Nelson, and H. Molina. 2003. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19: 813-822.
34. Ruggenenti, P., M. Noris, and G. Remuzzi. 2001. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 60: 831-846.
35. Pangburn, M. K., R. D. Schreiber, and H. J. Müller-Eberhard. 1981. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154: 856-867.
36. Nomura, A., K. Nishikawa, Y. Yuzawa, H. Okada, N. Okada, B. P. Morgan, S. J. Piddlesden, M. Nadai, T. Hasegawa, and S. Matsuo. 1995. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J. Clin. Invest. 96: 2348-2356.
37. Gill, D. B., M. Koomey, J. G. Cannon, and J. P. Atkinson. 2003. Down-regulation of CD46 by piliated Neisseria gonorrhoeae. J. Exp. Med. 198: 1313-1322.
38. Springall, T., N. S. Sheerin, K. Abe, V. M. Holers, H. Wan, and S. H. Sacks. 2001. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat. Med. 7: 801-806.
39. Wu, X., D. Spitzer, D. Mao, S. L. Peng, H. Molina, and J. P. Atkinson. 2008. Membrane protein Crry maintains homeostasis of the complement system. J. Immunol. 181: 2732-2740.
40. Ruseva, M. M., T. R. Hughes, R. M. Donev, B. Sivasankar, M. C. Pickering, X. Wu, C. L. Harris, and B. P. Morgan. 2009. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury. Mol. Immunol. 46: 803-811.
41. Rose, K. L., D. Paixao-Cavalcante, J. Fish, A. P. Manderson, T. H. Malik, A. E. Bygrave, T. Lin, S. H. Sacks, M. J. Walport, H. T. Cook, et al. 2008. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J. Clin. Invest. 118: 608-618.